Drug Profile


Latest Information Update: 28 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Center for Chemistry of Drugs
  • Class Antiglaucomas; Antihypertensives; Ischaemic heart disorder therapies; Oxadiazoles; Small molecules
  • Mechanism of Action Alpha adrenergic receptor antagonists; Beta-adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Angina pectoris; Glaucoma; Hypertension

Most Recent Events

  • 28 Aug 2007 Discontinued - Clinical-Phase-Unknown for Angina pectoris in Russia (PO)
  • 28 Aug 2007 Discontinued - Clinical-Phase-Unknown for Glaucoma in Russia (Ophthalmic)
  • 28 Aug 2007 Discontinued - Clinical-Phase-Unknown for Hypertension in Russia (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top